These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7986303)

  • 1. Syndrome X: 6 years later.
    Reaven GM
    J Intern Med Suppl; 1994; 736():13-22. PubMed ID: 7986303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for coronary heart disease in a population with a high prevalence of obesity and diabetes: a case-control study of the Polynesian population of Western Samoa.
    Wahi S; Gatzka CD; Sherrard B; Simpson H; Collins V; Dowse G; Zimmet P; Jennings G; Dart AM
    J Cardiovasc Risk; 1997 Jun; 4(3):173-8. PubMed ID: 9475671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
    Palaniappan LP; Kwan AC; Abbasi F; Lamendola C; McLaughlin TL; Reaven GM
    Metabolism; 2007 Jul; 56(7):899-904. PubMed ID: 17570249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH; Chunawala L; Linde R; Reaven GM
    J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clustering of impaired glucose tolerance, hyperinsulinemia and dyslipidemia in young north Indian patients with coronary heart disease: a preliminary case-control study.
    Misra A; Reddy RB; Reddy KS; Mohan A; Bajaj JS
    Indian Heart J; 1999; 51(3):275-80. PubMed ID: 10624065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of lipids to coronary heart disease in diabetes mellitus.
    Stewart MW; Laker MF; Alberti KG
    J Intern Med Suppl; 1994; 736():41-6. PubMed ID: 7986307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HRT mechanisms of action: carbohydrates.
    Stevenson JC; Proudler AJ; Walton C; Godsland IF
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():50-5. PubMed ID: 8199641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women.
    McLaughlin T; Abbasi F; Kim HS; Lamendola C; Schaaf P; Reaven G
    Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome X: a review.
    Timar O; Sestier F; Levy E
    Can J Cardiol; 2000 Jun; 16(6):779-89. PubMed ID: 10863169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    McLaughlin T; Abbasi F; Lamendola C; Reaven G
    Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidemia in type 2 diabetes.
    Krauss RM; Siri PW
    Med Clin North Am; 2004 Jul; 88(4):897-909, x. PubMed ID: 15308384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and dyslipidemia.
    Ginsberg HN; Tuck C
    Heart Fail Monit; 2001; 2(1):14-20. PubMed ID: 12634894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of syndrome X whose hyperglycemia, hyperlipidemia and hypertension were improved as accompanying with decreased insulin resistance].
    Hiramatsu S; Mimura K; Ono Y; Taniguchi S; Iwashige K; Umeda F; Nawata H
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):326-8. PubMed ID: 7851834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia.
    Reaven GM
    Diabetes Obes Metab; 2002 Jan; 4 Suppl 1():S13-8. PubMed ID: 11843950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.